"Graves Disease Treatment Market – Industry Trends and Forecast to 2028

Global Graves Disease Treatment Market, By Mechanism of Action (Anti-thyroid Agents, Beta Blockers, Corticosteroids and Others), Drugs (Propylthiouracil, Methimazole, Propranolol, Prednisone and Others), Diagnosis (Physical Exam, Blood Test, Radioactive Iodine Uptake Test, Ultrasound and Imaging Tests), Treatment (Medication, Radioactive Iodine Therapy, Surgery and Others), Route of Administration (Oral, Intravenous and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

The graves disease treatment market is expected to witness market growth at a rate of 4.50% in the forecast period of 2021 to 2028. Data Bridge Market Research report on graves disease treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the iodine disorder and thyroid tumors screening is escalating the growth of graves disease treatment market.

Access Full 350 Pages PDF Report @

https://www.databridgemarketresearch.com/reports/global-graves-disease-treatment-market

Graves’ disease can be referred to as an autoimmune disorder of the thyroid gland that triggers the hyperthyroidism, overproduction of the thyroid hormones. The immune system attacks the thyroid gland and triggers the swelling which results in overactive thyroid and extreme production of thyroid hormones.

**Segments**

- **Medication**: Medication is a key segment in the Graves Disease Treatment market, as it allows patients to manage symptoms effectively. Anti-thyroid drugs, beta-blockers, and radioactive iodine are commonly used medications to treat Graves' disease. These drugs work by regulating the production of thyroid hormones, alleviating hyperthyroidism symptoms.

- **Surgery**: Surgery is another significant segment in the Graves Disease Treatment market, particularly for patients who do not respond well to medication or have severe symptoms. Thyroidectomy, the surgical removal of the thyroid gland, is often recommended for such cases to control the overproduction of thyroid hormones.

- **Radioiodine Therapy**: Radioiodine therapy is a non-surgical treatment option for Graves' disease that involves the administration of radioactive iodine to destroy thyroid cells and reduce hormone production. This therapy is effective in managing hyperthyroidism symptoms and is often preferred by patients who are not suitable candidates for surgery.

**Market Players**

- **AbbVie Inc.**: AbbVie is a leading pharmaceutical company that offers treatments for various diseases, including Graves' disease. The company provides anti-thyroid medications and other therapeutic options to manage hyperthyroidism symptoms effectively.

- **Merck & Co., Inc.**: Merck is a prominent player in the Graves Disease Treatment market, offering a range of medications and treatment solutions for thyroid disorders. The company's research and development efforts focus on innovative therapies to address the unmet needs of patients with Graves' disease.

- **Pfizer Inc.**: Pfizer is a well-known pharmaceutical company with a portfolio of treatments for autoimmune diseases like Graves' disease. The company's product offerings include beta-blockers and other medications that help control hyperthyroidism symptoms and improve patients' quality of life.

The global Graves Disease Treatment Market is characterized by a growing demand for effective treatment options to manage hyperthyroidism symptoms and improve patient outcomes. Medication, surgeryThe global Graves Disease Treatment market is witnessing a significant growth trajectory driven by the increasing prevalence of hyperthyroidism and the rising demand for effective treatment options. One of the key segments in this market is medication, which plays a crucial role in managing symptoms associated with Graves' disease. Anti-thyroid drugs, beta-blockers, and radioactive iodine are the cornerstone medications used to regulate the production of thyroid hormones and alleviate hyperthyroidism symptoms. The market for medication in Graves Disease Treatment is expected to grow as more advanced and targeted therapies are developed to provide better symptom management and improve patient outcomes.

Surgery is another important segment in the Graves Disease Treatment market, particularly for patients who do not respond well to medication or have severe symptoms. Thyroidectomy, the surgical removal of the thyroid gland, is often recommended for such cases to control the overproduction of thyroid hormones. With advancements in surgical techniques and technology, the adoption of surgical procedures for Graves' disease treatment is likely to increase, contributing to the growth of this market segment.

Radioiodine therapy is also a significant segment in the Graves Disease Treatment market, offering a non-surgical treatment option for patients with Graves' disease. This therapy involves the administration of radioactive iodine to destroy thyroid cells and reduce hormone production, effectively managing hyperthyroidism symptoms. Radioiodine therapy is considered a safe and effective treatment option for patients who are not suitable candidates for surgery, further expanding the treatment landscape in the market.

Key market players such as AbbVie Inc., Merck & Co., Inc., and Pfizer Inc. play a crucial role in driving innovation and growth in the Graves Disease Treatment market. These pharmaceutical companies offer a range of medications and treatment solutions for Graves' disease, addressing the unmet needs of patients and improving their quality of life. With a focus on research and development, these market players continue to introduce new therapeutic options and advancements in treatment modalities, further enhancing the market dynamics and driving market growth.

Overall, the global Graves**Global Graves Disease Treatment Market Analysis**

- **Medication Segment**: The medication segment in the Graves Disease Treatment market is witnessing significant growth due to the increasing prevalence of hyperthyroidism and the demand for effective treatment options. Anti-thyroid drugs, beta-blockers, and radioactive iodine are key medications used to manage hyperthyroidism symptoms, providing patients with better symptom control and improved quality of life.

- **Surgery Segment**: The surgery segment in the Graves Disease Treatment market is crucial for patients who do not respond well to medication or have severe symptoms. Thyroidectomy, the surgical removal of the thyroid gland, plays a vital role in controlling the overproduction of thyroid hormones in such cases. With advancements in surgical techniques, the adoption of surgical procedures for Graves' disease treatment is expected to increase, contributing to the growth of this market segment.

- **Radioiodine Therapy Segment**: Radioiodine therapy is an important non-surgical treatment option for Graves' disease patients, involving the administration of radioactive iodine to reduce hormone production and manage hyperthyroidism symptoms effectively. This therapy offers a safe and efficient alternative for patients who are not suitable candidates for surgery, expanding the treatment options available in the market.

Market players like AbbVie Inc., Merck & Co., Inc., and Pfizer Inc. are driving innovation and growth in the Graves Disease Treatment market by offering a diverse range of medications and treatment solutions. These companies focus on research and development to introduce new therapeutic options and advancements

Table of Contents: Graves Disease Treatment Market

1 Introduction

2 Global Graves Disease Treatment Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Graves Disease Treatment Market, by Product Type

7 Graves Disease Treatment Market, by Modality

8 Graves Disease Treatment Market, by Type

9 Graves Disease Treatment Market, by Mode

10 Graves Disease Treatment Market, by End User

12 Graves Disease Treatment Market, by Geography

12 Graves Disease Treatment Market, Company Landscape

13 Swot Analysis

14 Company Profiles

Countries Studied:

1. North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
2. Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
3. Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
4. Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Objectives of the Report

• To carefully analyze and forecast the size of the Graves Disease Treatment market by value and volume.
• To estimate the market shares of major segments of the Graves Disease Treatment
• To showcase the development of the Graves Disease Treatment market in different parts of the world.
• To analyze and study micro-markets in terms of their contributions to the Graves Disease Treatment market, their prospects, and individual growth trends.
• To offer precise and useful details about factors affecting the growth of the Graves Disease Treatment
• To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Graves Disease Treatment market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Browse Trending Reports:

Buttocks Augmentation Market
Anti Rickettsial Treatment Market
Barbecue Bbq Sauces And Rubs Market
Bottle Display Packaging Market
Transcathetar Devices Market
Citrus Extract Market
Artificial Organ Bank Market
Brown Sequard Syndrome Treatment Market
Bread Maker Market
Concealed Weapon Detection Systems Market
Orthodontic Headgear Market
Bioresorbable Scaffolds Market
Betanin Market
Biotinidase Deficiency Market
Colostrum Market
Citral Market
Facial Tissue Paper Market
Adhesive Foam Tape Market
Pfeiffer Syndrome Market
Acaiberry Extract Market
Brugada Syndrome Treatment Market
Sitosterolemia Market
Disposable Slippers Market
Clinical Communication Software Market
Antimicrobial Nanocoatings Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"